Recent immunomodulatory strategies in transplantation

Immunological Investigations

Volumn 43, Issue 8, 2014, Pages 829-837

  Ebrahimi, Ammar ^a   Rahim, Fakher ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Exosomes; Immune rejection transplantation mesenchymal stem cells; Immunoisolation; Immunosuppression; Transplantation

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROLIDE;

AEROSOL; ALLOTRANSPLANTATION; APOPTOSIS; ARTICLE; EXOSOME; EXTRACORPOREAL PHOTOPHERESIS; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOBIOLOGY; IMMUNOISOLATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM SURVIVAL; LYMPH NODE IRRADIATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PHAGOSOME; PUVA; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES;

EXOSOMES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; MESENCHYMAL STROMAL CELLS; ORGAN TRANSPLANTATION; PHAGOSOMES; PHOTOPHERESIS;

EID: 84911114666     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2014.915414     Document Type: Article

References (67)

1. Augello A, Tasso R, Negrini SM. (2005). Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol, 35, 1482-90.
2. Bartholomew A, Sturgeon C, Siatskas M. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 30, 42-8.
3. Bianco P, Robey PG, Simmons PJ. (2008). Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell, 2, 313-19.
4. Brasile L, Glowacki P, Castracane J, Stubenitsky BM. (2010). Pretransplant kidney-specific treatment to eliminate the need for systemic immunosuppression. Transplantation, 90, 1294-8.
5. Brasile L, Glowacki P, Stubenitsky BM. (2011). Bioengineered skin allografts: A new method to prevent humoral response. ASAIO J, 57, 239-43.
6. Broady R, Levings MK. (2008). Graft-versus-host disease: Suppression by statins. Nat Med, 14, 1155-6.
7. Chabannes D, Hill M, Merieau E. (2007). A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood, 110, 3691-4.
8. Chen CP, Liu SH, Huang JP. (2009). Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats. Hum Reprod, 24, 154-65.
9. Chen FH, Tuan RS. (2008). Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther, 10, 223-31.
10. Chernysheva AD, Kirou KA, Crow MK. (2002). T cell proliferation induced by autologous non-T cells is a response to apoptotic cells processed by dendritic cells. J Immunol, 169, 1241-50.
11. Choi Y-S, Jeong J-A, Lim D-S. (2012). Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest, 41, 214-29.
12. Cohen PA, Ko JS, Storkus WS, et al. (2012). Myeloid-derived suppressor cells adhere to physiologic STAT3-vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunol Invest, 41, 680-710.
13. Corcione A, Benvenuto F, Ferretti E. (2006). Human mesenchymal stem cells modulate B-cell functions". Blood, 107, 367-72.
14. Crosbie PA, Woodhead MA. (2009). Long-term macrolide therapy in chronic inflammatory airway diseases. Euro Respir J, 33, 171-81.
15. Cruise GM, Hegre OD, Lamberti FV, et al. (1999). In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly (ethylene glycol) diacrylate membranes. Cell Transplant, 8, 293.
16. de Carvalho Bittencourt M, Perruche S, Contassot E, et al. (2001). Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood, 98, 224-30.
17. Desjardins M, Huber LA, Parton RG, Griffiths G. (1994). Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J Cell Biol, 124, 677-88.
18. Ebrahimi A, Lalvand N. (2013). Drug delivery using genetically modified mesenchymal stem cells: A promising targeted-delivery method. Hygeia J Drugs Med, 5, 90-104.
19. Edelson R, Berger C, Gasparro F, et al. (1987). Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New Engl J Med, 316, 297-303.
20. Gatza E, Rogers CE, Clouthier SG, et al. (2008). Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood, 112, 1515-21.
21. Gerdoni E, Gallo B, Casazza S. (2007). Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol, 61, 219-27.
22. Gerhardt SG, McDyer JF, Girgis RE, et al. (2003). Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: Results of a pilot study. Amer J Respir Crit Care Med, 168, 121-5.
23. Gleisner MA, Rosemblatt M, Fierro JA, Bono MR. (2011). Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Transplant Proc, 43, 2325-33.
24. Iacono AT, Johnson BA, Grgurich WF, et al. (2006). "A Randomized Trial of Inhaled Cyclosporine in Lung-Transplant Recipients". New Engl J Med, 354, 141-50.
25. Inaba K, Turley S, Yamaide F, et al. (1998). Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exper Med, 188, 2163-73.
26. Iwata H, Amemiya H, Matsuda T, et al. (1989). Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes, 38, 224-5.
27. Iyoda T, Shimoyama S, Liu K, et al. (2002). The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exper Med, 195, 1289-302.
28. Jones BJ, Brooke G, Atkinson K. (2007). Immunosuppression by placental indoleamine 2,3-dioxygenase: A role for mesenchymal stem cells. Placenta, 28, 1174-81.
29. Kanoh S, Rubin BK. (2010). Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev, 23, 590-615.
30. Kim SH, Lechman ER, Bianco N, Menon R, et al. (2005). Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis". The Journal of Immunology, 174, 6440-8.
31. Knobler R, Barr ML, Couriel DR, et al. (2009). Extracorporeal photopheresis: Past, present, and future. J Amer Acad Dermatol, 61, 652-65.
32. Kobashigawa JA, Katznelson S, Laks H. (1995). Effect of pravastatin on outcomes after cardiac transplantation. New Engl J Med, 333, 621-7.
33. Kwak B, Mulhaupt F, Myit S, Mach FO. (2000). Statins as a newly recognized type of immunomodulator. Nat Med, 6, 1399-402.
34. Le BK, Rasmusson I, Sundberg B. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363, 1439-41.
35. Lim F, Sun AM. (1980). Microencapsulated islets as bioartificial endocrine pancreas. Science, 210, 908-10.
36. Luis A, Ortiz FG, Christine M. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA, 100, 8407-11.
37. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M. (2007). Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med, 10, 459-66.
38. Monu NR, Frey AB. (2012). Myeloid-derived suppressor cells and anti-tumor T cells: A complex relationship. Immunol Invest, 41, 595-613.
39. Morrell MR, Despotis GJ, Lublin DM, et al. (2010). The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant, 29, 424-31.
40. Morelli AE. (2006). The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: Its impact on transplantation. Amer J Transplant, 6, 254-61.
41. Morelli AE, Larregina AT. (2010). Apoptotic cell-based therapies against transplant rejection: Role of recipient's dendritic cells. Apoptosis, 15, 1083-97.
42. Morelli AE, Larregina AT, Shufesky WJ, et al. (2003). Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood, 101, 611-20.
43. Nouri-Shirazi M, Guinet E. (2002). Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage1. Transplantation, 74, 1035-44.
44. Palmer SC, Craig JC, Navaneethan SD, et al. (2012). Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and metaanalysis. Ann Intern Med, 157, 263-75.
45. Pêche H, Heslan MI, Usal C, et al. (2003). Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection1. Transplantation, 76, 1503-10.
46. Peche H, Renaudin K, Beriou G, et al. (2006). Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Amer J Transplant, 6, 1541-50.
47. Pessach I, Shimoni A, Nagler A. (2012). Apoptotic cells in allogeneic hematopoietic stem cell transplantations: Turning trash into gold. Leukemia Lymphoma, 53, 2130-5.
48. Pittenger MF, Mackay AM, Beck SC. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-7.
49. Sakaida I, Terai S, Yamamoto N. (2004). Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology, 40, 1304-11.
50. Sauter B, Albert ML, Francisco L, et al. (2000). Consequences of Cell Death Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exper Med, 191, 423-34.
51. Segura E, Nicco C, Lombard B, et al. (2005). ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood, 106, 216-23.
52. Singh PP, LeMaire C, Tan JC, et al. (2011). Exosomes released from M. tuberculosis infected cells can suppress IFN-g mediated activation of naive macrophages. PLoS One, 6, e18564.
53. Skoberne M, Somersan S, Almodovar W, et al. (2006). The apoptotic-cell receptor CR3, but not avb5, is a regulator of human dendritic-cell immunostimulatory function. Blood, 108, 947-55.
54. Steffens S, Mach FO. (2006). "Drug Insight: Immunomodulatory effects of statins-potential benefits for renal patients? Nat Clin Pract Nephrol, 2, 378-87.
55. Stuart LM, Lucas M, Simpson C, et al. (2002). Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol, 168, 1627-35.
56. Stubenitsky BM, Brasile L, Rebellato LM, et al. (2009). Delayed skin allograft rejection following matrix membrane pretreatment. J Plast Reconstruct Aesth Surg, 62, 520-5.
57. Théry C, Duban L, Segura E, et al. (2002). Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol, 3, 1156-62.
58. Ureta G, Osorio F, Morales J, et al. (2007). Generation of dendritic cells with regulatory properties. Transplant Proc, 39, 633-7.
59. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. (2006). Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Amer J Respir Crit Care Med, 174, 566-70.
60. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, et al. (2002). Exosomes bearing HLAâ-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Inter Immunol, 14, 713-22.
61. Wang Z, Larregina AT, Shufesky WJ, et al. (2006). Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T Cells. Amer J Transplant, 6, 1297-311.
62. Whitford H, Walters EH, Levvey B, et al. (2002). Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: A double-blind, placebo-controlled trial1. Transplantation, 73, 1793-9.
63. Williams CA, Harry RA, McLeod JD. (2008). Apoptotic cells induce dendritic cell-mediated suppression via interferon-induced IDO. Immunology, 124, 89-101.
64. Xu DL, Liu Y, Tan JM, et al. (2004). Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donorâ-derived apoptotic cells. Scand J Immunol, 59, 536-44.
65. Zappia E, Casazza S, Pedemonte E. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106, 1755-61.
66. Zhang W, Ge W, Li C. (2004). Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev, 13, 263-71.
67. Zielinski A, Aebischer P. (1994). Chitosan as a matrix for mammalian cell encapsulation. Biomaterials, 15, 1049-56.